Therapeutic innovations, diminishing returns, and control rate preservation - Wikidata - wikimedia - TriplyDB

Therapeutic innovations, diminishing returns, and control rate preservation

Therapeutic innovations, diminishing returns, and control rate preservation

http://www.wikidata.org/entity/Q34712057

about

Searching the clinical fitness landscape Critical Limb Ischemia: Current Trends and Future Directions Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes.The Burden of the "False-Negatives" in Clinical Development: Analyses of Current and Alternative Scenarios and Corrective Measures.The new heart failure diet: less salt restriction, more micronutrients.Aggregating and disaggregating patients in clinical trials and their subgroup analyses.What should we do when traditional research fails?

P2860

Q24288704-EACAB7C9-7A0D-4849-AD83-D50AEF8D6234 Q26767021-862C83C4-AA47-4302-A68E-A27DD25EC26A Q36131480-D30D5270-D1CA-48E0-9F7E-40A4A614DBE1 Q40135662-9C642FA9-5F5B-4D06-A608-55CE41C36F44 Q42409647-CA8E6D08-2B05-410C-9907-27C553622094 Q42417534-8DCEC27F-04A2-4C59-AEBF-421EB00B1B01 Q47292571-0C318427-4D7C-4E02-A7F1-A3553EA786C3

P2860

Therapeutic innovations, diminishing returns, and control rate preservation

http://www.wikidata.org/entity/Q34712057

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Therapeutic innovations, diminishing returns, and control rate preservation

@ast

Therapeutic innovations, diminishing returns, and control rate preservation

@en

Therapeutic innovations, diminishing returns, and control rate preservation

@nl

type

label

Therapeutic innovations, diminishing returns, and control rate preservation

@ast

Therapeutic innovations, diminishing returns, and control rate preservation

@en

Therapeutic innovations, diminishing returns, and control rate preservation

@nl

prefLabel

Therapeutic innovations, diminishing returns, and control rate preservation

@ast

Therapeutic innovations, diminishing returns, and control rate preservation

@en

Therapeutic innovations, diminishing returns, and control rate preservation

@nl

P1433

Q34712057-01DD0361-2C30-4C21-923D-AE6C2E245AEF

P1476

Q34712057-28B43B98-34FC-4ED0-9DB3-9EBBB4DE2371

P2093

Q34712057-3D1D7A2E-BE20-4594-BD54-95F60EE3E9A6

Q34712057-4891B476-345A-47D5-AF18-68C40D6548BD

P2860

Q34712057-005C7641-43BF-4CB0-A706-1F04F81CF498

Q34712057-1E3DB395-DD72-472F-83DD-3178E1DAC844

Q34712057-4A67600E-5177-4543-8159-604ADF1D48C7

Q34712057-5C20276E-889F-4FA8-92ED-C69D48534B12

Q34712057-5DCF6912-BBED-4FCC-AC28-0755E97E1B81

Q34712057-68175678-BB0C-46A5-B5AA-D6584F28590E

Q34712057-74F90EA8-4450-4910-807A-8C64B6A56A3F

Q34712057-7A4941F1-EEEF-4B9A-9FD1-53E43CF5CC80

Q34712057-96A04A4B-F6F1-4E40-B85E-94883B0D625F

Q34712057-A7C57540-6940-456C-97BE-016E36A7E2ED

P304

Q34712057-706836C4-3D7E-4634-8D96-DEAFB3B05A8F

P31

Q34712057-8A990163-CFC2-4965-90CE-1556BFD30C11

P356

Q34712057-305739AA-4413-4193-95B9-6CBA7223EC91

P407

Q34712057-1D7892E3-9BC1-49AF-8F38-5EF75FD6F657

P433

Q34712057-9682A857-9BA2-4FD3-B838-B93F0D1B3189

P478

Q34712057-A8801B76-014D-455C-B3D9-813D4730F39D

P577

Q34712057-C655998E-4CCA-40F8-8B82-5BBD6BD48745

P5875

Q34712057-C30D6AFB-B0EF-41E8-87EF-61A7BB21C7BF

P698

Q34712057-D923E652-702E-4D17-9048-E4B1ACFA4297

P932

Q34712057-6C0BF071-4ED1-4EDD-BC0F-28841F89B3A6

P356

P1433

Journal of the American Medical Association

P1476

Therapeutic innovations, diminishing returns, and control rate preservation

@en

P2093

David M Kent

http://www.w3.org/2001/XMLSchema#string

Thomas A Trikalinos

http://www.w3.org/2001/XMLSchema#string

P2860

Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE)

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials.

Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis.

Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach

Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.

P304

2254-2256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2009.1679

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

302

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40027777

http://www.w3.org/2001/XMLSchema#string

P698

19934428

http://www.w3.org/2001/XMLSchema#string

P932

3063072

http://www.w3.org/2001/XMLSchema#string